Oral Administration of Grape Seed Proanthocyanidin Extracts Downregulate RAGE Dependant Nuclear Factor- Kappa BP65 Expression in the Hippocampus of Streptozotocin Induced Diabetic Rats

Abstract

Chronic degenerative brain disease in diabetes, known as ‘diabetic encephalopathy’, is a recognized complication that can occur due to long-standing diabetes in patients. It is defined by chronic cognitive disturbance and it is thought to relate to regional tissue pathological changes in the brain. Furthermore, hyperglycemia induced activation of the AGE_S/RAGE/NF-κB pathway may play an important role in the pathogenesis of the degenerative changes seen in the diabetic hippocampus. To help prevent the development of and to potentially treat this brain disease, effective interventions directed toward key molecular target(s) are required. Grape seed proanthocyanidin extracts (GSPE), which are the anti-oxidants derived from grape seeds, have been reported to possess a variety of potent properties. As a consequence, they may have therapeutic effects in the prevention and treatment of complications in patients with diabetes. In this study, we firstly examined whether GSPE could attenuate the structural degenerative changes in the diabetic hippocampus in a rodent model of diabetes. Secondly, we addressed if such effects of GSPE may be occurring through modulation of the receptor for advanced glycation end products (RAGE) and/or nuclear factor-kappa BP65 (NF-κBP65). Hippocampi from GSPE treated STZ induced diabetic rats were immunohistochemically stained for glial fibrillary acidic protein, RAGE and NF-κBP65 and for morphological observations. Western blot was used to detect the proteins of RAGE and NF-κBP65. Real time, reverse transcriptase coupled to polymerase chain reaction was used for quantitative determination of mRNA for RAGE and NF-κBP65. Analysis of data showed that long term chronic hyperglycemia caused the overexpression of AGE_S/RAGE and NF-κBp65 in the CA region of hippocampus in STZ induced diabetic rats. GSPE decreased the expression of RAGE and NF-κBP65 at a daily oral dosage of 250 mg/kg. This study provides indication that GSPE can prevent structural changes of diabetes in the rat brain and it suggests that GSPE might be a useful remedy in the treatment of diabetic encephalopathy. In addition, it implicates the potential pathological role of RAGE and NF-κBP65 in diabetic encephalopathy.

Key words

diabetes - encephalopathy - grape seed proanthocyanidin extracts - receptor for advanced glycation end products - nuclear factor-kappa BP65

References

• 1 Intensive diabetes management . implications of the DCCT and UKPDS.  Diabetes Educ. 2002;  28 735-740
• 2 Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).  Diabetes Metab Res Rev. 2006;  22 376-384
• 3 Bagchi D, Bagchi M, Stohs S, Ray SD, Sen CK, Preuss HG. Cellular protection with proanthocyanidins derived from grape seeds.  Ann N Y Acad Sci. 2002;  957 260-270
• 4 Bagchi D, Sen CK, Ray SD, Das DK, Bagchi M, Preuss HG, Vinson JA. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract.  Mutat Res. 2003;  523-524 87-97
• 5 Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundorfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.  J Clin Invest. 2004;  114 1741-1751
• 6 Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.  Diabetes. 2001;  50 2792-2808
• 7 Biessels GJ. Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms.  Neth J Med. 1999;  54 35-45
• 8 Bischoff A, Zimmermann A. Diabetic encephalopathy. Does it exist?.  Acta Neurol Belg. 1979;  79 460-468
• 9 Calkin AC, Allen TJ. Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.  Am J Cardiovasc Drugs. 2006;  6 15-40
• 10 Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment.  J Exp Med. 2003;  198 1507-1515
• 11 Devi A, Jolitha AB, Ishii N. Grape seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats.  Med Sci Monit. 2006;  12 BR124-129
• 12 Groop PH, Forsblom C, Thomas MC. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.  Nat Clin Pract Endocrinol Metab. 2005;  1 100-110
• 13 Harati Y. Diabetes and the nervous system.  Endocrinol Metab Clin North Am. 1996;  25 325-359
• 14 Haslbeck KM, Neundorfer B, Schlotzer-Schrehardtt U, Bierhaus A, Schleicher E, Pauli E, Haslbeck M, Hecht M, Nawroth P, Heuss D. Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies?.  Neurol Res. 2007;  29 103-110
• 15 Haslbeck KM, Schleicher E, Bierhaus A, Nawroth P, Haslbeck M, Neundorfer B, Heuss D. The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).  Exp Clin Endocrinol Diabetes. 2005;  113 288-291
• 16 Kim H, Deshane J, Barnes S, Meleth S. Proteomics analysis of the actions of grape seed extract in rat brain: technological and biological implications for the study of the actions of psychoactive compounds.  Life Sci. 2006;  78 2060-2065
• 17 King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complications.  Endocrinol Metab Clin North Am. 1996;  25 255-270
• 18 King GL, Kunisaki M, Nishio Y, Inoguchi T, Shiba T, Xia P. Biochemical and molecular mechanisms in the development of diabetic vascular complications.  Diabetes. 1996;  45 (Suppl) 3 S105-S108
• 19 Korf ES, White LR, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study.  Diabetes Care. 2006;  29 2268-2274
• 20 Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, Plachky J, Grone HJ, Kurschus FC, Schmidt AM, Yan SD, Martin E, Schleicher E, Stern DM, Hammerling GG, Nawroth PP, Arnold B. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.  J Clin Invest. 2004;  113 1641-1650
• 21 Makita ZVH, Cerami A, Bucala R. Immunochemical detection of advanced glycosylation end products in vivo.  J Biol Chem. 1992;  267 5133-5138
• 22 Manschot SM, Brands AM, Grond J van der, Kessels RP, Algra A, Kappelle LJ, Biessels GJ. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes.  Diabetes. 2006;  55 1106-1113
• 23 Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging.  Neurobiol Aging. 2005;  26 1 26-30
• 24 Mijnhout GS, Scheltens P, Diamant M, Biessels GJ, Wessels AM, Simsek S, Snoek FJ, Heine RJ. Diabetic encephalopathy: A concept in need of a definition.  Diabetologia. 2006;  49 1447-1448
• 25 Pinent M, Blay M, Blade MC, Salvado MJ, Arola L, Ardevol A. Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines.  Endocrinology. 2004;  145 4985-4990
• 26 Preuss HG, Bagchi D, Bagchi M. Protective effects of a novel niacin-bound chromium complex and a grape seed proanthocyanidin extract on advancing age and various aspects of syndrome X.  Ann N Y Acad Sci. 2002;  957 250-259
• 27 Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.  Glycobiology. 2005;  15 16R-28R
• 28 Ramasamy R, Yan SF, Schmidt AM. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.  Trends Cardiovasc Med. 2005;  15 237-243
• 29 Rask-Madsen C, King GL. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance.  Arterioscler Thromb Vasc Biol. 2005;  25 487-496
• 30 Saravia FE, Beauquis J, Revsin Y, Homo-Delarche F, Kloet ER de, Nicola AF De. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment.  Cell Mol Neurobiol. 2006;  26 941-955
• 31 Shi J, Yu J, Pohorly JE, Kakuda Y. Polyphenolics in grape seeds-biochemistry and functionality.  J Med Food. 2003;  6 291-299
• 32 Toth C, Schmidt AM, Tuor UI, Francis G, Foniok T, Brussee V, Kaur J, Yan SF, Martinez JA, Barber PA, Buchan A, Zochodne DW. Diabetes, leukoencephalopathy and rage.  Neurobiol Dis. 2006;  23 445-461
• 33 Vigna GB, Costantini F, Aldini G, Carini M, Catapano A, Schena F, Tangerini A, Zanca R, Bombardelli E, Morazzoni P, Mezzetti A, Fellin R, Maffei Facino R. Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers.  Metabolism. 2003;  52 1250-1257
• 34 Yamakoshi J, Saito M, Kataoka S, Kikuchi M. Safety evaluation of proanthocyanidin-rich extract from grape seeds.  Food Chem Toxicol. 2002;  40 599-607
• 35 Zhang FL, Gao HQ, Wu JM, Ma YB, You BA, Li BY, Xuan JH. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells.  J Cardiovasc Pharmacol. 2006;  48 47-53

Correspondence